Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · S-8 POS

NABRIVA THERAPEUTICS PLC

SEC Filing

Filed Oct 20, 2023Accepted Oct 19, 2023, 4:23 PM EDTCIK 1641640Accession 0001104659-23-110238
Share

Company context

Historical securities (1)

Recent company filings

  1. 15-12G filingOct 25, 2023
  2. EFFECT filingOct 24, 2023
  3. POS AM filingOct 20, 2023
  4. S-8 POS filingOct 20, 2023
  5. S-8 POS filingOct 20, 2023

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗